Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography?

Background: To decide whether a person with certain characteristics should be given any kind of intervention to prevent a cardiovascular event, it would be helpful to classify subjects in low, medium and high risk categories. The study evaluated which well known cerebrovascular and cardiovascular correlates, in particular fibrinogen level and ECG characteristics, are able to predict the occurrence of stroke in men of the general population using data from three European cohorts participating in EUROSTROKE. Methods: EUROSTROKE is a collaborative project among ongoing European population based cohort studies and designed as a prospective nested case-control study. For each stroke case two controls were sampled. Strokes were classified according to MONICA criteria or reviewed by a panel of four neurologists. Complete data were available of 698 men (219 stroke events) from cohorts in Cardiff (84 cases/200 controls), Kuopio (74/148) and Rotterdam (61/131). Multivariable logistic regression modeling was used to evaluate which information from history, physical examination (for example, blood pressure), blood lipids, and fibrinogen and ECG measurements independently contributed to the prediction of stroke. The area under receiver operating characteristic curve (ROC area) was used to estimate the predictive ability of models. Results: Independent predictors from medical history and physical examination were age, stroke history, medically treated hypertension, smoking, diabetes mellitus and diastolic blood pressure. The ROC area of this model was 0.69. After validating and transforming this model to an easy applicable rule, 40% of all future stroke cases could be predicted. Adding pulse rate, body mass index, blood lipids, fibrinogen level and ECG parameters did not improve the classification of subjects in low, medium and high risk. Results were similar when fibrinogen was dichotomised at the upper tertile or quintile. Conclusion: In the general male population the future occurrence of stroke may be predicted using easy obtainable information from medical history and physical examination. Measurement of pulse rate, body mass index, blood lipids, fibrinogen level and ECG characteristics do not contribute to the risk stratification of stroke and have no value in the screening for stroke in the general male population.

[1]  F. Song,et al.  Cholesterol lowering and mortality: the importance of considering initial level of risk. , 1993, BMJ.

[2]  M. Mancini,et al.  Measuring plasma fibrinogen to predict stroke and myocardial infarction. , 1990, Arteriosclerosis.

[3]  K. Anderson,et al.  An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.

[4]  Eaft Study Group Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993, The Lancet.

[5]  J. Hanley,et al.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.

[6]  P. Poole‐Wilson,et al.  Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. , 1994, Atherosclerosis.

[7]  R D Cebul,et al.  The importance of disease prevalence in transporting clinical prediction rules. The case of streptococcal pharyngitis. , 1986, Annals of internal medicine.

[8]  P. Macfarlane,et al.  West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996 .

[9]  L Wilhelmsen,et al.  Analysis of risk factors for stroke in a cohort of men born in 1913. , 1987, The New England journal of medicine.

[10]  Roderick J. A. Little Regression with Missing X's: A Review , 1992 .

[11]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[12]  O S Miettinen,et al.  Proportion of disease caused or prevented by a given exposure, trait or intervention. , 1974, American journal of epidemiology.

[13]  V. Geissbühler,et al.  Waterbirths: A Comparative Study , 2000, Fetal Diagnosis and Therapy.

[14]  T. Lancet,et al.  West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996, The Lancet.

[15]  H. Mcintosh,et al.  Smoking as a risk factor. , 1978, Heart & lung : the journal of critical care.

[16]  The Treatment of Coronary Heart Disease: An Update , 2001, Current medical research and opinion.

[17]  A. Fehily,et al.  Caerphilly and Speedwell collaborative heart disease studies. The Caerphilly and Speedwell Collaborative Group. , 1984, Journal of epidemiology and community health.

[18]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[19]  Arno W. Hoes,et al.  Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. , 1997, Circulation.

[20]  J. Bamford,et al.  Classification and natural history of clinically identifiable subtypes of cerebral infarction , 1991, The Lancet.

[21]  I. U. Haq,et al.  Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease , 1995, The Lancet.

[22]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.

[23]  L. Wilhelmsen,et al.  Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.

[24]  T. Wyller,et al.  Lifestyle Factors and Risk of Cerebral Infarction , 1992, Stroke.

[25]  B. Efron Estimating the Error Rate of a Prediction Rule: Improvement on Cross-Validation , 1983 .

[26]  F. Harrell,et al.  Regression models in clinical studies: determining relationships between predictors and response. , 1988, Journal of the National Cancer Institute.

[27]  P. Poole‐Wilson,et al.  Prevention of coronary heart disease in clinical practice , 1994 .

[28]  P. Whincup,et al.  Femoral atherosclerosis in an older British population: prevalence and risk factors. , 2000, Atherosclerosis.

[29]  J A Kors,et al.  Methodology of the Modular ECG Analysis System MEANS , 1990, Methods of Information in Medicine.

[30]  R. Rauramaa,et al.  HDL, HDL2, and HDL3 Subfractions, and the Risk of Acute Myocardial Infarction: A Prospective Population Study in Eastern Finnish Men , 1991, Circulation.

[31]  D E Grobbee,et al.  Does drug treatment improve survival? Reconciling the trials in mild‐to-moderate hypertension , 1995, Journal of hypertension.

[32]  J. L. Willems,et al.  The diagnostic performance of computer programs for the interpretation of electrocardiograms. , 1992, The New England journal of medicine.

[33]  V. Salomaa,et al.  The FINMONICA Stroke Register. Community-based stroke registration and analysis of stroke incidence in Finland, 1983-1985. , 1992, American journal of epidemiology.

[34]  C. Bulpitt,et al.  Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. , 1993, BMJ.

[35]  I. U. Haq,et al.  Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men , 1999, Heart.

[36]  C. Warlow,et al.  Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes. , 1991, BMJ.

[37]  P. Poole‐Wilson,et al.  Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. , 1994, European heart journal.

[38]  I. U. Haq,et al.  Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease , 1995, The Lancet.

[39]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[40]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[41]  A. Hofman,et al.  Cardiovascular risk and all-cause mortality; A 12 year follow-up study in The Netherlands , 1993, European Journal of Epidemiology.

[42]  Leandro Provinciali,et al.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .

[43]  S Greenland,et al.  A critical look at methods for handling missing covariates in epidemiologic regression analyses. , 1995, American journal of epidemiology.

[44]  R S Wigton,et al.  Transportability of a decision rule for the diagnosis of streptococcal pharyngitis. , 1986, Archives of internal medicine.

[45]  A. Hofman,et al.  Determinants of disease and disability in the elderly: The Rotterdam elderly study , 1991, European Journal of Epidemiology.

[46]  N Rifai,et al.  Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. , 2001, JAMA.

[47]  J Nyboe,et al.  Stroke incidence and risk factors for stroke in Copenhagen, Denmark. , 1988, Stroke.

[48]  Factor V Arg506Gln mutation is not associated with cardiovascular mortality in older women. , 1999, American journal of epidemiology.

[49]  David W. Hosmer,et al.  Applied Logistic Regression , 1991 .

[50]  M. Elisaf The Treatment of Coronary Heart Disease: An Update , 2001, Current medical research and opinion.

[51]  T. Truelsen,et al.  Comparison of Probability of Stroke Between the Copenhagen City Heart Study and the Framingham Study , 1994, Stroke.

[52]  P. Koudstaal,et al.  We need stronger predictors of major vascular events in patients with a recent transient ischemic attack or nondisabling stroke. Dutch TIA Trial Study Group. , 1997, Stroke.

[53]  J. Ferro,et al.  Incidence and risk factors of ischaemic and haemorrhagic stroke in Europe , 1996 .

[54]  A. Hoes,et al.  Prevalence, Determinants, and Misclassification of Myocardial Infarction in the Elderly , 1997, Epidemiology.

[55]  R B D'Agostino,et al.  Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.